Vasavi Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 22-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.93 Cr
as on 22-12-2024
- Revenue %
(FY 2022)
- Profit 3028.57%
(FY 2022)
- Net Worth 0.10%
(FY 2022)
- Total Assets 17.61%
(FY 2022)
About Vasavi Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹3.93 Cr.
Nageswara Nunna, Sirisha Jonnada, and Sampath Jonnada serve as directors at the Company.
- CIN/LLPIN
U15100AP2020PTC116050
- Company No.
116050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2020
- Date of AGM
15 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vasavi Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nageswara Nunna  | Managing Director | 14-Oct-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sirisha Jonnada | Director | 14-Oct-2020 | Current |
| Sampath Jonnada | Additional Director | 27-Jul-2023 | Current |
Financial Performance of Vasavi Biotech.
Vasavi Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 3028.57% increase in profit. The company's net worth moved up by a moderate rise of 0.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vasavi Biotech?
Unlock access to Vasavi Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 Apr 2023 | ₹1.93 Cr | Open |
Canara Bank Creation Date: 10 Apr 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Vasavi Biotech?
Vasavi Biotech has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vasavi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vasavi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
